...
首页> 外文期刊>British Journal of Clinical Pharmacology >Fixed dose drug combinations (FDCs): rational or irrational: a view point.
【24h】

Fixed dose drug combinations (FDCs): rational or irrational: a view point.

机译:固定剂量药物组合(FDC):合理或不合理:观点。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Combination products, also known as fixed dose drug combinations (FDCs), are combinations of two or more active drugs in a single dosage form. The Food and Drug Administration, USA defines a combination product as 'a product composed of any combination of a drug and a device or a biological product and a device or a drug and a biological product or a drug, device, and a biological product' . It is widely accepted that most drugs should be formulated as single compounds. Fixed ratio combina-tion products are acceptable only when the dosage of each ingredient meets the requirement of a defined population group and when the combination has a proven advantage over single compounds administered separately in therapeutic effect, safety or compliance.
机译:组合产品,也称为固定剂量药物组合(FDC),是两种或多种活性药物在单一剂型中的组合。美国食品和药物管理局将组合产品定义为“由药物和设备或生物产品以及设备或药物和生物产品或药物,设备和生物产品的任何组合组成的产品” 。众所周知,大多数药物应配制成单一化合物。只有当每种成分的剂量满足特定人群的要求,并且该组合物在治疗效果,安全性或依从性方面优于单独施用的单一化合物时,固定比例组合产品才是可接受的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号